Rigel Pharmaceuticals (RIGL) Other Operating Expenses (2013 - 2026)
Rigel Pharmaceuticals (RIGL) posted quarterly Other Operating Expenses of $4.6 million for Q1 2026, up 4.47% year-over-year from $4.4 million in Q1 2025, and down 22.65% quarter-over-quarter from $6.0 million in Q4 2025.
Rigel Pharmaceuticals (RIGL) Other Operating Expenses (2013 - 2026) Analysis & Trends
Rigel Pharmaceuticals' Other Operating Expenses history runs 13 years deep, the most recent figure standing at $4.6 million for Q1 2026.
- In Q1 2026, Other Operating Expenses rose 4.47% year-over-year to $4.6 million; the TTM figure through Mar 2026 stood at $19.8 million (down 5.77% YoY), while the FY2025 annual figure was $19.6 million, up 5.22% from the prior year.
- Other Operating Expenses for Q1 2026 stood at $4.6 million, down from $6.0 million in the prior quarter.
- The five-year high for Other Operating Expenses was $14.5 million in Q4 2022, with the low at $121000.0 in Q1 2022.
- The 5-year median for Other Operating Expenses is $3.8 million (2023), against an average of $3.9 million.
- Peak annual rise in Other Operating Expenses reached 707.44% in 2023, while the deepest fall reached 73.91% in 2023.
- Rigel Pharmaceuticals' Other Operating Expenses stood at $14.5 million in 2022, then plunged by 73.91% to $3.8 million in 2023, then surged by 52.74% to $5.8 million in 2024, then gained by 2.87% to $6.0 million in 2025, then fell by 22.65% to $4.6 million in 2026.
- Business Quant data shows RIGL's Other Operating Expenses at $4.6 million in Q1 2026, $6.0 million in Q4 2025, and $4.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Rigel Pharmaceuticals | 795.39 Mn | 700.06 Mn | 70.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.53 Mn |
| Mar 31, 2026 | 4.61 Mn |
| Dec 31, 2025 | 5.96 Mn |
| Sep 30, 2025 | 4.75 Mn |
| Jun 30, 2025 | 4.50 Mn |
| Mar 31, 2025 | 4.41 Mn |
| Dec 31, 2024 | 5.79 Mn |
| Sep 30, 2024 | 8.03 Mn |
| Jun 30, 2024 | 2.81 Mn |
| Mar 31, 2024 | 2.03 Mn |
| Dec 31, 2023 | 3.79 Mn |
| Sep 30, 2023 | 1.27 Mn |
| Jun 30, 2023 | 1.08 Mn |
| Mar 31, 2023 | 977,000.00 |
| Dec 31, 2022 | 14.53 Mn |
| Sep 30, 2022 | 250,000.00 |
| Jun 30, 2022 | 1.04 Mn |
| Mar 31, 2022 | 121,000.00 |
| Dec 31, 2021 | 4.01 Mn |
| Sep 30, 2021 | 151,000.00 |